|
28 Apr 2009 |
Aeras and Crucell Announce Start of TB Infant Study in South Africa
|
|
28 Apr 2009 |
PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vac
|
|
27 Apr 2009 |
Dynavax Presents Additional Phase 3 Data for HEPLISAV Hepatitis B Vaccine at EASL Medical Conference
|
|
27 Apr 2009 |
Juvaris BioTherapeutics Vaccine Adjuvant, JVRS-100, Generates Superior T-Cell Mediated Immune Responses to Influenza in Clinical Trial
|
|
27 Apr 2009 |
VaxInnates Seasonal Flu Vaccine Candidate Shown Safe and Immunogenic in Phase I Study
|
|
24 Apr 2009 |
GlobeImmune's Hepatitis C Therapeutic Vaccine, GI-5005, Improves EVR Rates to 94 Percent in Phase 2 Clinical Trial
|
|
24 Apr 2009 |
Opexa Publication of Tovaxin Clinical Data in Journal of Clinical Immunology
|
|
23 Apr 2009 |
Phase 1 trial of whole-parasite malaria vaccine to begin
|
|
23 Apr 2009 |
Vical Reports Publication of Key Research Findings for Immunotherapeutic Herpes Vaccine
|
|
22 Apr 2009 |
Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrine's Fully Human Anti-PS Antibody in Prostate Cancer Model
|
|
21 Apr 2009 |
Circassia's Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients
|
|
20 Apr 2009 |
Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer
|
|
20 Apr 2009 |
Generex Data Presented At American Association for Cancer Research 100th Annual Meeting
|
|
16 Apr 2009 |
Genetic Immunity, InPlay: Second Phase II Clinical Trial Commences in Italy on Company's Lead Product Candidate DermaVir Patch HIV Vaccine
|
|
16 Apr 2009 |
GlobeImmune Initiates Phase 1 Clinical Trial With NCI in CEA Over-Expressing Cancers
|
|
14 Apr 2009 |
NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains
|
|
14 Apr 2009 |
BioVex Commences OncoVEX (GM-CSF) Phase 3 Trial in Metastatic Melanoma
|
|
07 Apr 2009 |
Intercell starts a Phase I clinical trial for a new Streptococcus pneumoniae vaccine
|
|
02 Apr 2009 |
Intercell announces European approval of new vaccine, IXIARO®, to prevent Japanese Encephalitis
|
|
30 Mar 2009 |
Ixiaro(R) receives FDA approval for the prevention of Japanese Encephalitis
|
|
19 Mar 2009 |
ImVisioN Therapeutics Reports Positive Phase I Clinical Results for Treatment of Cat Dander Allergy
|
|
17 Mar 2009 |
Cytos Biotechnology announces alignment of resources following setback in the development of its hypertension vaccine CYT006-AngQb
|
|
16 Mar 2009 |
Nobilon Advances First Vaccine Into Human Trials
|
|
16 Mar 2009 |
Neovacs Announces the Publication of a PNAS Article on Anti-IFN Kinoid Active Immunization in Lupus
|
|
05 Mar 2009 |
Opexa Provides Key Quality of Life Data on Tovaxin for Multiple Sclerosis
|
